Our results indicated that CPX induced the phosphorylation of Cdc25A, which promoted protein degradation of Cdc25A in rhabdomyosarcoma (Rh30) and breast cancer (MDA-MB-231) cells. Here, CDC25A is linked to breast carcinoma.